In addition, some other noninvasive screening tests of CRC including stool blood tests, serum CEA, CA19-9 and blood septin9 gene tests were used to reduce the incidence and mortality of CRC22,36–38. Here, SEPTIN9 is linked to colorectal carcinoma.